Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

134.05
Delayed Data
As of Aug 28
 +0.30 / +0.22%
Today’s Change
90.99
Today|||52-Week Range
143.45
+12.84%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line29.6M-162.9M-687.6M-742.7M
 
 
 
 
 
Depreciation35.0M38.2M48.4M63.3M
 
 
 
 
 
Total Other Cash Flow279.7M369.7M877.7M177.1M
 
 
 
 
 
Funds From Operations336.8M281.6M-46.5M-502.1M
 
 
 
 
 
Funds From/For Other Operating Expenses193.1M13.8M5.1M11.1M
 
 
 
 
 
Net Cash Flow - Operating Activities143.7M267.8M-51.6M-513.2M
 
 
 
 
 
 
InvestingIncrease In Investments-721.5M-1.7B-2.4B-1.4B
 
 
 
 
 
Decrease In Investments1.0B1.4B2.3B1.6B
 
 
 
 
 
Capital Expenditures-34.6M-71.1M-51.4M-51.2M
 
 
 
 
 
Net Assets From Acquisitions -60.0M0.000.000.00
 
 
Other Investing - Uses-183.0K-18.9M0.00-10.2M
 
 
 
 
Other Investing - Sources12.7M2.2M61.4M1.6M
 
 
 
 
 
Net Cash Flow Investing212.4M-425.8M-54.1M74.0M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.00302.3M
 
 
Long Term Debt Reduction-155.0M-21.5M-83.7M-81.7M
 
 
 
 
 
Net Proceeds Stock Sale124.9M191.7M265.9M274.6M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing900.0K2.0M0.002.2M
 
 
 
 
Other Uses - Financing95.0M0.001.3M0.00
 
 
 
Net Cash Flow - Financing-124.2M172.2M180.9M497.4M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash214.0K-141.0K4.7M-2.2M
 
 
 
 
 
 
Net Change In Cash231.9M14.2M75.2M58.1M